$ABVX Highly misleading report and love that they say they will most likely have exited by the time you read it. Exit liquidity if i've ever seen it. At best, one legitimate safety question. Don't be fooled.
Average stock after Scorpion Capital report is up double digits later since 2021.
The China thesis has to explain ABTECT-2. It enrolled 636 patients with no Chinese sites listed. At week 8, remission was 19.8% on 50 mg vs 6.3% on placebo (p=0.0001). Endoscopic improvement was 35.5% vs 10.1%.
Skin safety deserves review. In randomized maintenance, non-melanoma skin cancers were 4/195 at 50 mg, 1/193 at 25 mg and 1/192 on placebo. Part 2 had two cases per dose and no placebo. Abivax should publish the case breakdown and photosafety data.
$ABVX Highly misleading report and love that they say they will most likely have exited by the time you read it. Exit liquidity if i've ever seen it. At best, one legitimate safety question. Don't be fooled.
Average stock after Scorpion Capital report is up double digits later since 2021.
The China thesis has to explain ABTECT-2. It enrolled 636 patients with no Chinese sites listed. At week 8, remission was 19.8% on 50 mg vs 6.3% on placebo (p=0.0001). Endoscopic improvement was 35.5% vs 10.1%.
Skin safety deserves review. In randomized maintenance, non-melanoma skin cancers were 4/195 at 50 mg, 1/193 at 25 mg and 1/192 on placebo. Part 2 had two cases per dose and no placebo. Abivax should publish the case breakdown and photosafety data.
NEW: We are short $ABVX Abivax SA - a biotech fraud for the ages. Report now live on our site, along with four scientific abstracts based upon our laboratory experiments. An 11-month investigation, our most intensive research to date.
I'd temper the view slightly. I do agree, there are of course individuals that lack discipline. But there are many that just don't have the right information or know how to process information to make the decisions.
I actually say this from deep personal experience. Our product is the first agentic autonomous personal finance app and a nice chunk of our customer base our paycheck to paycheck and I can tell you they deeply want help. They've had no one give them the right information to make the right decisions.
It's this reason why i'm so bullish Ai. I'm watching human behavior change with the right information.
I don't. These are families that are barely paycheck to paycheck. I don't blame them at all.
To the extent that they are susceptible to narratives, it was dumb on the industries part to fuel a bad one.
I am so hopeful about what AI will do for the future. Wish we would have played that up more
@signulll 100% agree.
Check out https://t.co/sLixzLPptC
Launched a few weeks ago and the love from our customers has been incredible (and retention incredibly strong)
Truly intelligent, agentic autonomous personal finance
We’ve been quietly building for 18 months to get to this point
💯
We've built to the ultimate personal finance product and learned a lot along the way. It was us doing the work for our customers (autonomous ai) that was the breakthrough.
Majority of Americans do not want to just chat with their finances. Finances create anxiety. They want solutions. They don't know what to ask.
For how you are describing it, i agree. But the big nuance is specialized software can do way more than the personal agents.
We just launched full autonomous personal finance (building toward super app) and our retention is off the charts. Stronger than all personal agents.
It's because we can leverage the tools for incredible depth that a personal agent won't be able to.
Traditional budget apps, traditional software with a fancy UI, yes you are completely right.
But the same tech that allows personal agents to run, can take a specialized system way further.
I will say we will probably explore plugging into them because our users are showing almost all engage deeply through imessage and natural language so don't want an app.